Spots Global Cancer Trial Database for osteosarcoma in children
Every month we try and update this database with for osteosarcoma in children cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| SARC038: Phase 2 Study of Regorafenib and Nivolumab in Osteosarcoma | NCT04803877 | Osteosarcoma Osteosarcoma in... Osteosarcoma Re... Osteosarcoma Me... | Regorafenib 40 ... Regorafenib 20M... Nivolumab | 5 Years - | Sarcoma Alliance for Research through Collaboration | |
| Qarziba for Patients in Relapsed/Refractory High-grade Osteosarcoma | NCT05558280 | Osteosarcoma in... | Dinutuximab bet... | 1 Year - 25 Years | Azienda Ospedaliera Ospedale Infantile Regina Margherita Sant'Anna | |
| Stereotactic Body Radiotherapy (SBRT) for Pulmonary Metastases in Ewing Sarcoma, Rhabdomyosarcoma, and Wilms Tumors | NCT02581384 | Ewing Sarcoma Rhabdomyosarcom... Wilms Tumor Osteosarcoma Non-Rhabdomyosa... Renal Tumor Rhabdoid Tumor Clear Cell Rena... Sarcoma Sarcoma, Ewing Soft Tissue Sar... | Stereotactic Bo... | - 21 Years | Dana-Farber Cancer Institute | |
| Long-term Evaluation of the Quality of Life of Former Patients Treated With Orthopedic Surgery, With or Without Radiotherapy | NCT04644913 | Osteosarcoma in... | Quality of life... | 18 Years - | Institut Cancerologie de l'Ouest | |
| Stereotactic Body Radiotherapy (SBRT) for Pulmonary Metastases in Ewing Sarcoma, Rhabdomyosarcoma, and Wilms Tumors | NCT02581384 | Ewing Sarcoma Rhabdomyosarcom... Wilms Tumor Osteosarcoma Non-Rhabdomyosa... Renal Tumor Rhabdoid Tumor Clear Cell Rena... Sarcoma Sarcoma, Ewing Soft Tissue Sar... | Stereotactic Bo... | - 21 Years | Dana-Farber Cancer Institute | |
| Qarziba for Patients in Relapsed/Refractory High-grade Osteosarcoma | NCT05558280 | Osteosarcoma in... | Dinutuximab bet... | 1 Year - 25 Years | Azienda Ospedaliera Ospedale Infantile Regina Margherita Sant'Anna | |
| 3D Printed Personalized Extendable Prosthesis | NCT05794594 | Osteosarcoma in... | 3D printed pers... | 6 Years - 18 Years | Children's Hospital of Chongqing Medical University | |
| Integrated Clinical-radiological Analysis of Hypoxia Markers in Pediatric Osteosarcomas | NCT05107843 | Osteosarcoma in... | 1 Year - 20 Years | University Hospital, Strasbourg, France | ||
| Long-term Evaluation of the Quality of Life of Former Patients Treated With Orthopedic Surgery, With or Without Radiotherapy | NCT04644913 | Osteosarcoma in... | Quality of life... | 18 Years - | Institut Cancerologie de l'Ouest | |
| Effects of Maintenance Cabozantinib+BSC Versus BSC in Children and AYA With Osteosarcoma | NCT06341712 | Osteosarcoma Osteosarcoma in... Osteosarcoma in... | Cabozantinib Best Supportive... Best Supportive... | 5 Years - 30 Years | Ipsen | |
| Nivolumab or Nivolumab and Azacitidine in Patients With Recurrent, Resectable Osteosarcoma | NCT03628209 | Osteosarcoma Osteosarcoma in... Osteosarcoma Re... Sarcoma | Nivolumab Azacitidine Post Treatment ... | - 39 Years | H. Lee Moffitt Cancer Center and Research Institute | |
| Integrated Clinical-radiological Analysis of Hypoxia Markers in Pediatric Osteosarcomas | NCT05107843 | Osteosarcoma in... | 1 Year - 20 Years | University Hospital, Strasbourg, France | ||
| Qarziba for Patients in Relapsed/Refractory High-grade Osteosarcoma | NCT05558280 | Osteosarcoma in... | Dinutuximab bet... | 1 Year - 25 Years | Azienda Ospedaliera Ospedale Infantile Regina Margherita Sant'Anna |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
